Work

Suzetrigine: A promising analgesic targeting voltage-gated sodium channel

Year: 2026

Type: article

Abstract: ABSTRACT: Chronic pain management continues to challenge clinicians due to limitations in efficacy and tolerability of current pharmacological therapies. Suzetrigine, a first-in-class selective sodium channel blocker, has emerged as a promising agent for the treatment of neuropathic and chronic pain syndromes. Preclinical and clinical data highlight suzetrigine's unique sodium channel selectivity, reduced central nervous system side effects, and encouraging efficacy signals in neuropathic pain, trigeminal neuralgia, and refractory pain states. Early-phase trials report favorable safety and tolerability compared to conventional sodium channel blockers. Suzetrigine represents a promising new analgesic agent with a novel mechanism of action. Further Phase 3 studies are warranted to establish its role in pain medicine.

Source: Indian Journal of Pharmacology

DOI: 10.4103/ijp.ijp_854_25

Authors: Samarjit Dey, M. V. Eeshwar, Vamshidhar Chamala, Sunit Kumar Gupta

Institution: All India Institute of Medical Sciences, Mangalagiri

Language: English

Topic: Pain Mechanisms and Treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W7159585443

FWCI:

Cites:

Cited by:

Related to: